×
About 49,245 results

ALLMedicine™ Hepatitis C Center

Research & Reviews  16,585 results

Changes in health-related quality of life for HCV-infected people who inject drugs on o...
https://doi.org/10.1093/cid/ciab669
Clinical Infectious Diseases : an Official Publication Of... Gormley MA, Akiyama MJ et. al.

Aug 1st, 2021 - Although efforts to treat hepatitis C virus (HCV) in people who inject drugs (PWID) yield high rates of sustained virologic response (SVR), the relationship between successful HCV treatment and health-related quality of life (HRQOL) among PWID is ...

Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 20...
https://doi.org/10.1016/j.clml.2021.06.014
Clinical Lymphoma, Myeloma & Leukemia; Alkrekshi A, Kassem A et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) is a significant healthcare problem affecting ~1% of the United States population. Meta-analyses of epidemiological studies reported a strong association between non-Hodgkin's lymphoma (NHL) and HCV. Direct oncogenic proper...

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

Are oral lichen planus patients at high risk of hepatitis C? A case-control study.
https://doi.org/10.1016/j.jormas.2021.07.013
Journal of Stomatology, Oral and Maxillofacial Surgery; Pitak-Arnnop P, Subbalekha K et. al.

Aug 1st, 2021 - To assess the correlation between oral lichen planus (OLP) and viral hepatitis C (HCV). This retrospective case-control study included a sample of OLP patients in a 3-year interval. The predictor variable was the presence of OLP (yes/no). The outc...

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envel...
https://doi.org/10.1371/journal.pone.0255336
PloS One; Prentoe J, Janitzek CM et. al.

Jul 31st, 2021 - Yearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die from related morbidities, including liver cirrhosis and cancer. Effective treatments exis...

see more →

Guidelines  37 results

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral In...
https://doi.org/10.1016/j.jogc.2020.09.007
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wilson RD

Dec 15th, 2020 - This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive s...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 22nd, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.1123
JAMA , Owens DK et. al.

Mar 3rd, 2020 - Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, in...

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-...
https://doi.org/10.1002/hep.31060
Hepatology (Baltimore, Md.) References; Ghany MG, Morgan TR et. al.

Dec 10th, 2019 - Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.|2019|Ghany MG,Morgan TR, ,|diagnosis,the...

see more →

Drugs  57 results see all →

Clinicaltrials.gov  958 results

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
https://clinicaltrials.gov/ct2/show/NCT03303599

Apr 24th, 2020 - The interferon- and ribavirin- (RBV) free combination regimen of glecaprevir plus pibrentasvir (GLE/PIB) for the treatment of genotypes 1 to 6 of chronic hepatitis C (CHC) viral infection has been shown to be safe and effective in randomized contr...

Oral Microbiome of Patients With Hepatitis C Virus Infection
https://clinicaltrials.gov/ct2/show/NCT03682549

Apr 24th, 2020 - Human oral cavity is a great habitat for more than 600 species of bacteria, known as oral microbiota, living in equilibrium. Oral microbiota plays an important role in maintaining oral health; however when the balance in oral bacterial population ...

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
https://clinicaltrials.gov/ct2/show/NCT00004850

Apr 22nd, 2020 - At initiation of this study in 1991, approximately 0.6% of U.S. blood donors were identified as having antibody to the hepatitis C virus (anti-HCV). This represented 72,000 of the estimated 12 million annual U.S. blood donations. By investigating ...

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
https://clinicaltrials.gov/ct2/show/NCT01350648

Apr 20th, 2020 - Chronic viral hepatitis is a major health problem affecting millions globally. The immunosuppressed population, especially those with HIV infection, remains at particular risk and the incidence of hepatocellular carcinoma (HCC) is increasing in th...

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4
https://clinicaltrials.gov/ct2/show/NCT03381859

Apr 20th, 2020 - Primary Efficacy Objective -To assess whether a 12-week treatment course with oral 50 mg elbasvir plus 100 mg grazoprevir given in a single daily dose to treatment-naïve patients with end-stage renal disease (ESRD) and infected with genotype 4 (GT...

see more →

News  2,032 results

HIV: NIDA's Avenir Grant Awarded to Hansel Tookes, MD, MPH, for Tele-Harm Reduction Research
https://www.medscape.com/viewarticle/954836

Jul 15th, 2021 - "There are no interventions that have been shown to be effective in attaining viral suppression in people who inject drugs (PWID)," 2021 HIV/AIDS Research Avenir Award winner Hansel Tookes, MD, infectious disease specialist at the University of Mi...

Rapid Core Antigen HCV Tests Could Expand Accessibility
https://www.medscape.com/viewarticle/954141

Jul 1st, 2021 - A proposed rapid diagnostic test for hepatitis C viral infections that combines an inexpensive but lower-sensitivity core-antigen test with lab RNA confirmation of negative tests could expand testing and same-day initiation of antiviral therapy in...

The Pandemic Hurt Patients With Liver Disease in Many Ways
https://www.medscape.com/viewarticle/953986

Jun 30th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic has worsened the health of patients with liver disease worldwide, researchers say. Not only does liver disease make people m...

Hepatitis C Antivirals May Fight SARS-CoV-2
https://www.medscape.com/viewarticle/953902

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. An antiviral drug combination used to treat hepatitis C and an anti-protozoal drug may also work against SARS-CoV-2, researchers say. Sofosbuvir/...

New Program to Develop Antivirals for COVID-19
https://www.medscape.com/viewarticle/953314

Jun 17th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Biden administration announced Thursday a $3.2 billion program dedicated to developing drugs that fight COVID-19 in its early stages, along wi...

see more →

Patient Education  29 results see all →